annual EBIT:
-$3.94B-$41.00M(-1.05%)Summary
- As of today (May 21, 2025), MRNA annual earnings before interest & taxes is -$3.94 billion, with the most recent change of -$41.00 million (-1.05%) on December 31, 2024.
- During the last 3 years, MRNA annual EBIT has fallen by -$17.24 billion (-129.67%).
- MRNA annual EBIT is now -129.67% below its all-time high of $13.30 billion, reached on December 31, 2021.
Performance
MRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$963.00M+$215.00M(+18.25%)Summary
- As of today (May 21, 2025), MRNA quarterly earnings before interest & taxes is -$963.00 million, with the most recent change of +$215.00 million (+18.25%) on March 31, 2025.
- Over the past year, MRNA quarterly EBIT has increased by +$196.00 million (+16.91%).
- MRNA quarterly EBIT is now -117.80% below its all-time high of $5.41 billion, reached on December 31, 2021.
Performance
MRNA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$3.39B+$196.00M(+5.47%)Summary
- As of today (May 21, 2025), MRNA TTM earnings before interest & taxes is -$3.39 billion, with the most recent change of +$196.00 million (+5.47%) on March 31, 2025.
- Over the past year, MRNA TTM EBIT has increased by +$1.38 billion (+28.95%).
- MRNA TTM EBIT is now -120.82% below its all-time high of $16.27 billion, reached on March 31, 2022.
Performance
MRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MRNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.1% | +16.9% | +28.9% |
| 3 y3 years | -129.7% | -122.7% | -120.8% |
| 5 y5 years | -622.5% | -682.9% | -529.6% |
MRNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.7% | at low | -122.7% | +50.6% | -120.8% | +28.9% |
| 5 y | 5-year | -129.7% | at low | -117.8% | +50.6% | -120.8% | +28.9% |
| alltime | all time | -129.7% | at low | -117.8% | +50.6% | -120.8% | +28.9% |
MRNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$963.00M(-18.3%) | -$3.39B(-5.5%) |
| Dec 2024 | -$3.94B(+1.1%) | -$1.18B(-4463.0%) | -$3.58B(+53.8%) |
| Sep 2024 | - | $27.00M(-102.1%) | -$2.33B(-45.9%) |
| Jun 2024 | - | -$1.27B(+9.8%) | -$4.30B(-9.7%) |
| Mar 2024 | - | -$1.16B(-1625.0%) | -$4.77B(+22.1%) |
| Dec 2023 | -$3.90B(-140.6%) | $76.00M(-103.9%) | -$3.90B(+56.2%) |
| Sep 2023 | - | -$1.95B(+12.2%) | -$2.50B(-470.8%) |
| Jun 2023 | - | -$1.74B(+486.5%) | $674.00M(-86.2%) |
| Mar 2023 | - | -$296.00M(-120.0%) | $4.89B(-48.1%) |
| Dec 2022 | $9.60B(-27.8%) | $1.48B(+20.9%) | $9.42B(-29.4%) |
| Sep 2022 | - | $1.23B(-50.6%) | $13.35B(-14.9%) |
| Jun 2022 | - | $2.48B(-41.5%) | $15.68B(-3.6%) |
| Mar 2022 | - | $4.24B(-21.7%) | $16.27B(+22.4%) |
| Dec 2021 | $13.30B(-1842.6%) | $5.41B(+52.1%) | $13.30B(+75.2%) |
| Sep 2021 | - | $3.56B(+15.9%) | $7.59B(+99.5%) |
| Jun 2021 | - | $3.07B(+142.9%) | $3.81B(+510.8%) |
| Mar 2021 | - | $1.26B(-526.7%) | $623.00M(-181.7%) |
| Dec 2020 | -$763.00M(+39.7%) | -$296.00M(+28.7%) | -$763.00M(+21.7%) |
| Sep 2020 | - | -$230.00M(+101.8%) | -$626.70M(+20.9%) |
| Jun 2020 | - | -$114.00M(-7.3%) | -$518.43M(-3.6%) |
| Mar 2020 | - | -$123.00M(-23.0%) | -$537.93M(-1.5%) |
| Dec 2019 | -$546.00M(+43.2%) | -$159.70M(+31.2%) | -$546.00M(+3.8%) |
| Sep 2019 | - | -$121.74M(-8.8%) | -$526.03M(+8.9%) |
| Jun 2019 | - | -$133.50M(+1.9%) | -$483.11M(+9.8%) |
| Mar 2019 | - | -$131.07M(-6.2%) | -$440.03M(+15.4%) |
| Dec 2018 | -$381.31M(+49.0%) | -$139.73M(+77.3%) | -$381.31M(+41.3%) |
| Sep 2018 | - | -$78.81M(-12.8%) | -$269.92M(+40.5%) |
| Jun 2018 | - | -$90.42M(+25.0%) | -$192.05M(+86.8%) |
| Mar 2018 | - | -$72.35M(+155.3%) | -$102.79M(+226.2%) |
| Dec 2017 | -$255.86M(+14.3%) | -$28.34M(+2889.3%) | -$31.51M(+759.4%) |
| Sep 2017 | - | -$947.90K(-18.0%) | -$3.67M(+30.2%) |
| Jun 2017 | - | -$1.16M(+8.0%) | -$2.82M(+57.4%) |
| Mar 2017 | - | -$1.07M(+117.3%) | -$1.79M(+114.8%) |
| Dec 2016 | -$223.77M(-6803.7%) | - | - |
| Dec 2016 | - | -$492.50K(+404.1%) | -$832.80K(-113.1%) |
| Sep 2016 | - | -$97.70K(-23.9%) | $6.37M(+17.2%) |
| Jun 2016 | - | -$128.40K(+12.4%) | $5.43M(+19.7%) |
| Mar 2016 | - | -$114.20K(-101.7%) | $4.54M(+36.0%) |
| Dec 2015 | $3.34M(-161.0%) | $6.71M(-749.9%) | $3.34M(+37.2%) |
| Sep 2015 | - | -$1.03M(+1.0%) | $2.43M(-166.5%) |
| Jun 2015 | - | -$1.02M(-22.3%) | -$3.66M(-384.7%) |
| Mar 2015 | - | -$1.31M(-122.7%) | $1.28M(-123.5%) |
| Dec 2014 | -$5.47M(+302.0%) | $5.80M(-181.5%) | -$5.47M(-58.6%) |
| Sep 2014 | - | -$7.12M(-281.7%) | -$13.21M(+88.7%) |
| Jun 2014 | - | $3.92M(-148.6%) | -$7.00M(-37.0%) |
| Mar 2014 | - | -$8.07M(+316.0%) | -$11.11M(+593.0%) |
| Dec 2013 | -$1.36M(-82.5%) | -$1.94M(+112.7%) | -$1.60M(-63.8%) |
| Sep 2013 | - | -$912.00K(+390.3%) | -$4.43M(-12.6%) |
| Jun 2013 | - | -$186.00K(-113.0%) | -$5.06M(+107.0%) |
| Mar 2013 | - | $1.44M(-130.1%) | -$2.45M(-68.6%) |
| Dec 2012 | -$7.79M(-72.5%) | -$4.76M(+207.5%) | -$7.79M(-60.4%) |
| Sep 2012 | - | -$1.55M(-163.7%) | -$19.67M(-12.6%) |
| Jun 2012 | - | $2.43M(-162.2%) | -$22.51M(-25.8%) |
| Mar 2012 | - | -$3.91M(-76.5%) | -$30.33M(-3.6%) |
| Dec 2011 | -$28.28M(+13.5%) | -$16.64M(+279.4%) | -$31.46M(+61.4%) |
| Sep 2011 | - | -$4.39M(-18.6%) | -$19.50M(-15.6%) |
| Jun 2011 | - | -$5.39M(+7.0%) | -$23.09M(+8.6%) |
| Mar 2011 | - | -$5.04M(+7.7%) | -$21.25M(-4.2%) |
| Dec 2010 | -$24.93M(+143.5%) | -$4.68M(-41.4%) | -$22.19M(+6.7%) |
| Sep 2010 | - | -$7.98M(+124.3%) | -$20.80M(+4.9%) |
| Jun 2010 | - | -$3.56M(-40.5%) | -$19.83M(-16.1%) |
| Mar 2010 | - | -$5.97M(+81.7%) | -$23.64M(+142.8%) |
| Dec 2009 | -$10.24M | -$3.29M(-53.1%) | -$9.73M(-47.4%) |
| Sep 2009 | - | -$7.01M(-4.8%) | -$18.50M(-13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$7.36M(-192.9%) | -$21.26M(-24.4%) |
| Mar 2009 | - | $7.93M(-165.8%) | -$28.13M(-44.5%) |
| Dec 2008 | -$50.69M(-7.1%) | -$12.05M(+23.2%) | -$50.69M(-0.5%) |
| Sep 2008 | - | -$9.78M(-31.3%) | -$50.95M(-12.4%) |
| Jun 2008 | - | -$14.23M(-2.7%) | -$58.13M(+2.1%) |
| Mar 2008 | - | -$14.63M(+18.8%) | -$56.93M(+4.4%) |
| Dec 2007 | -$54.53M(+86.0%) | -$12.31M(-27.4%) | -$54.53M(+2.3%) |
| Sep 2007 | - | -$16.97M(+30.2%) | -$53.32M(+19.1%) |
| Jun 2007 | - | -$13.03M(+6.6%) | -$44.75M(+36.1%) |
| Mar 2007 | - | -$12.23M(+10.2%) | -$32.88M(+12.1%) |
| Dec 2006 | -$29.32M(-13.3%) | -$11.10M(+32.2%) | -$29.32M(+5.8%) |
| Sep 2006 | - | -$8.40M(+628.4%) | -$27.70M(-2.9%) |
| Jun 2006 | - | -$1.15M(-86.7%) | -$28.55M(-20.9%) |
| Mar 2006 | - | -$8.67M(-8.6%) | -$36.08M(+6.8%) |
| Dec 2005 | -$33.80M(+18.6%) | -$9.48M(+2.7%) | -$33.80M(+11.8%) |
| Sep 2005 | - | -$9.24M(+6.3%) | -$30.24M(+6.0%) |
| Jun 2005 | - | -$8.69M(+36.1%) | -$28.52M(+4.6%) |
| Mar 2005 | - | -$6.39M(+7.9%) | -$27.27M(-4.3%) |
| Dec 2004 | -$28.49M(+358.7%) | -$5.92M(-21.3%) | -$28.49M(-0.0%) |
| Sep 2004 | - | -$7.53M(+1.2%) | -$28.50M(+4.7%) |
| Jun 2004 | - | -$7.44M(-2.1%) | -$27.22M(+147.9%) |
| Mar 2004 | - | -$7.60M(+28.1%) | -$10.98M(+76.8%) |
| Dec 2003 | -$6.21M(-52.2%) | -$5.93M(-5.0%) | -$6.21M(+15.5%) |
| Sep 2003 | - | -$6.25M(-171.0%) | -$5.38M(+106.1%) |
| Jun 2003 | - | $8.80M(-410.7%) | -$2.61M(-79.9%) |
| Mar 2003 | - | -$2.83M(-44.5%) | -$12.96M(-0.2%) |
| Dec 2002 | -$12.99M(+36.0%) | -$5.10M(+46.6%) | -$12.99M(+18.3%) |
| Sep 2002 | - | -$3.48M(+124.1%) | -$10.98M(+16.9%) |
| Jun 2002 | - | -$1.55M(-45.8%) | -$9.40M(-6.1%) |
| Mar 2002 | - | -$2.86M(-7.4%) | -$10.01M(+4.8%) |
| Dec 2001 | -$9.55M(-7.6%) | -$3.09M(+63.2%) | -$9.55M(-5.9%) |
| Sep 2001 | - | -$1.89M(-12.4%) | -$10.15M(+0.5%) |
| Jun 2001 | - | -$2.16M(-10.0%) | -$10.11M(-2.5%) |
| Mar 2001 | - | -$2.40M(-35.0%) | -$10.36M(+0.3%) |
| Dec 2000 | -$10.34M(+9.3%) | -$3.69M(+99.9%) | -$10.34M(-2.4%) |
| Sep 2000 | - | -$1.85M(-23.5%) | -$10.59M(-1.1%) |
| Jun 2000 | - | -$2.42M(+1.8%) | -$10.71M(+7.2%) |
| Mar 2000 | - | -$2.38M(-39.9%) | -$9.99M(-0.2%) |
| Dec 1999 | -$9.45M(+301.9%) | -$3.95M(+101.5%) | -$10.02M(+17.6%) |
| Sep 1999 | - | -$1.96M(+15.4%) | -$8.51M(+24.3%) |
| Jun 1999 | - | -$1.70M(-29.2%) | -$6.85M(+28.0%) |
| Mar 1999 | - | -$2.40M(-2.1%) | -$5.35M(+69.8%) |
| Dec 1998 | -$2.35M(-60.8%) | -$2.45M(+717.3%) | -$3.15M(+1.7%) |
| Sep 1998 | - | -$300.00K(+50.0%) | -$3.10M(-31.1%) |
| Jun 1998 | - | -$200.00K(0.0%) | -$4.50M(-19.6%) |
| Mar 1998 | - | -$200.00K(-91.7%) | -$5.60M(-8.2%) |
| Dec 1997 | -$6.00M(+1100.0%) | -$2.40M(+41.2%) | -$6.10M(+64.9%) |
| Sep 1997 | - | -$1.70M(+30.8%) | -$3.70M(+85.0%) |
| Jun 1997 | - | -$1.30M(+85.7%) | -$2.00M(+300.0%) |
| Mar 1997 | - | -$700.00K(<-9900.0%) | -$500.00K(<-9900.0%) |
| Dec 1996 | -$500.00K(+400.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 1996 | -$100.00K(0.0%) | $200.00K(+100.0%) | -$100.00K(-66.7%) |
| Mar 1996 | - | $100.00K(-133.3%) | -$300.00K(-25.0%) |
| Dec 1995 | - | -$300.00K(+200.0%) | -$400.00K(+100.0%) |
| Sep 1995 | - | -$100.00K(<-9900.0%) | -$200.00K(<-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(-100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(-200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna annual earnings before interest & taxes?
- What is the all time high annual EBIT for Moderna?
- What is Moderna annual EBIT year-on-year change?
- What is Moderna quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Moderna?
- What is Moderna quarterly EBIT year-on-year change?
- What is Moderna TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Moderna?
- What is Moderna TTM EBIT year-on-year change?
What is Moderna annual earnings before interest & taxes?
The current annual EBIT of MRNA is -$3.94B
What is the all time high annual EBIT for Moderna?
Moderna all-time high annual earnings before interest & taxes is $13.30B
What is Moderna annual EBIT year-on-year change?
Over the past year, MRNA annual earnings before interest & taxes has changed by -$41.00M (-1.05%)
What is Moderna quarterly earnings before interest & taxes?
The current quarterly EBIT of MRNA is -$963.00M
What is the all time high quarterly EBIT for Moderna?
Moderna all-time high quarterly earnings before interest & taxes is $5.41B
What is Moderna quarterly EBIT year-on-year change?
Over the past year, MRNA quarterly earnings before interest & taxes has changed by +$196.00M (+16.91%)
What is Moderna TTM earnings before interest & taxes?
The current TTM EBIT of MRNA is -$3.39B
What is the all time high TTM EBIT for Moderna?
Moderna all-time high TTM earnings before interest & taxes is $16.27B
What is Moderna TTM EBIT year-on-year change?
Over the past year, MRNA TTM earnings before interest & taxes has changed by +$1.38B (+28.95%)